Roche appoints new head for pharma business; changes corporate structure
This article was originally published in Scrip
Executive Summary
Roche is changing the structure of its corporate team to reflect the innovative nature of its business, following the integration of Genentech. The company has eliminated the CEO position from its divisions, with all unit heads reporting directly to group CEO Severin Schwan.